project id: TCGA-BLCA; case submitter id: TCGA-DK-AA75; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 8.9; age at index: 82; days to birth: -30090; days to death: 340; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1931; year of death: 2013; age at diagnosis: 30090; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.3; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Anterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Anterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 272; initial weight: 240.0; sample id: 5346c3ec-3060-40c5-8ad4-c6e4d37c8909; sample submitter id: TCGA-DK-AA75-01A; portion id: 01c4e335-b5b7-4a46-8908-884497045dab; portion submitter id: TCGA-DK-AA75-01A-11; slide id: 3077c4ef-6c0d-4290-849f-7dd900a4b422; slide submitter id: TCGA-DK-AA75-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;